tDCS in Adults With ASD and/or ADHD Without Intellectual Disability (NCT06946433) | Clinical Trial Compass
CompletedNot Applicable
tDCS in Adults With ASD and/or ADHD Without Intellectual Disability
Spain25 participantsStarted 2022-11-07
Plain-language summary
The goal of this clinical trial is to learn about the safety and tolerability of transcranial direct current stimulation (tDCS) combined with cognitive training in adults with Autism Spectrum Disorder (ASD) and/or Attention-Deficit/Hyperactivity Disorder (ADHD).
The main question it aims to answer is:
Is tDCS safe and well-tolerated in adults with ASD and/or ADHD?
Researchers will compare active tDCS to a sham (placebo-like) stimulation to evaluate safety and tolerability.
Participants will:
Receive either active or sham tDCS for 20 minutes daily over 10 consecutive workdays
Undergo stimulation with the anode placed at F3 and the cathode at Fp2
Complete daily cognitive training exercises using the NeuronUP platform during stimulation
Attend baseline and follow-up assessments to monitor for any side effects or discomfort related to the intervention
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Adults aged 18 to 55 years
Clinical diagnosis of Autism Spectrum Disorder (ASD) and/or Attention-Deficit/Hyperactivity Disorder (ADHD) confirmed via medical records or structured clinical interview
Able to provide informed consent
Fluent in the language used for assessments and cognitive training tasks
Stable medication regimen (if applicable) for at least 4 weeks prior to enrollment
Willing and able to attend 10 consecutive weekday sessions and follow-up assessment
Exclusion Criteria:
History of epilepsy, seizures, or significant neurological disorder (e.g., traumatic brain injury, stroke)
Current diagnosis of psychotic disorder or bipolar disorder
Presence of metal implants in the head (excluding dental work), pacemaker, or other contraindications to tDCS
Current substance use disorder (within past 6 months)
Pregnant or planning to become pregnant during the study period
Participation in another intervention study within the last 30 days
Any condition that, in the opinion of the investigators, may make participation unsafe or interfere with study procedures
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Timeframe: Throughout the 10-day intervention period and at follow-up (up to 2 weeks post-intervention)
Trial details
NCT IDNCT06946433
SponsorHospital Universitari Vall d'Hebron Research Institute